Does DEGARELIX Cause Injection site swelling? 183 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Injection site swelling have been filed in association with DEGARELIX (FIRMAGON). This represents 4.8% of all adverse event reports for DEGARELIX.
183
Reports of Injection site swelling with DEGARELIX
4.8%
of all DEGARELIX reports
3
Deaths
25
Hospitalizations
How Dangerous Is Injection site swelling From DEGARELIX?
Of the 183 reports, 3 (1.6%) resulted in death, 25 (13.7%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEGARELIX. However, 183 reports have been filed with the FAERS database.
What Other Side Effects Does DEGARELIX Cause?
Injection site pain (296)
Injection site erythema (246)
Hot flush (199)
Fatigue (195)
Product storage error (177)
Pyrexia (170)
Off label use (128)
Asthenia (123)
Death (120)
Injection site mass (118)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which DEGARELIX Alternatives Have Lower Injection site swelling Risk?
DEGARELIX vs DELAFLOXACIN MEGLUMINE
DEGARELIX vs DELAMANID
DEGARELIX vs DELANDISTROGENE MOXEPARVOVEC-ROKL
DEGARELIX vs DELAVIRDINE
DEGARELIX vs DELORAZEPAM